If you’ve noticed dramatic physical transformations among prominent executives, celebrities, and high performers in recent years, there may be a specific protocol behind those results. During an appearance on the Huberman Lab podcast, Dr. Abud Bakri discussed what he described as a growing trend among elite circles: the Trinity Stack.
According to Dr. Bakri, the approach combines three interventions that target different biological systems simultaneously.
“People are now stacking their GLP-1 as their insulin sensitivity tool, their growth hormone or their GHR and their androgen modulation therapies as this trinity stack to get very fit, very healthy quickly,” he explained to host Andrew Huberman.
Each component serves a distinct purpose.
The first pillar consists of GLP-1 agonists, a class of treatments that includes well-known drugs such as Ozempic and Mounjaro. These improve insulin sensitivity and promote significant fat loss.
The second element involves growth hormone or growth hormone-releasing peptides, which are often used to support recovery, preserve lean muscle mass, and improve body composition.
The final component is androgen modulation, most commonly through testosterone replacement therapy (TRT), which can enhance muscle development and support hormonal health.
Dr. Bakri said that combining these three approaches has become increasingly common among affluent individuals seeking rapid physical transformation.
“So a lot of these transformations you see in CEOs and celebrities and stuff is using a combination of those three things,” he said.
He then offered examples of how such protocols are often structured.
“You know your TRT plus maybe Anavar with tirzepatide or retatrutide whatever it may be and then using a growth hormone modulation,” he said. “If you can afford growth hormone, or that’s more ipamorelin, and you’re seeing people lose a lot of fat, gain a lot of muscle in short amounts of time.”
While the results may appear impressive, Dr. Bakri acknowledged that the long-term consequences remain uncertain.
“Is that healthy? We’ll find out,” he said. “But that is like the celebrity protocol.”
What separates the Trinity Stack from more conventional optimization strategies is the deliberate combination of three separate hormonal and metabolic pathways.
Individually, each therapy has legitimate clinical applications. Together, proponents believe they can produce body composition changes at a speed and scale that would be difficult to achieve through any single intervention alone.
Cost remains one of the biggest barriers to adoption. Pharma-grade growth hormone from major manufacturers can cost thousands of dollars per month, making the full protocol inaccessible to most people.
Although compounded alternatives and peptide-based secretagogues can reduce expenses, the complete stack described by Dr. Bakri largely remains a tool reserved for those with substantial financial resources.
Long-term research on this specific combination of therapies is still limited.
